Metraipolis › archive › dc_fed06a0410da

Variability in anthracycline dose conversions and cardiotoxicity monitoring: insights from hospital pharmacists on institutional protocols in oncology practice — Europe PMC PMID:42133079

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42133079
DOI
10.1007/s00520-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-02T06:40:59.074Z
SHA-256 of the archived text
8eeb7ed716d7433daa10f4a2f352efaf87f5c61388f1739f7991ec9ad9de9f6d
Stable URL of this page
https://metraipolis.com/documento/dc_fed06a0410da

How to cite

Variability in anthracycline dose conversions and cardiotoxicity monitoring: insights from hospital pharmacists on institutional protocols in oncology practice — Europe PMC PMID:42133079 — Europe PMC (en), https://europepmc.org/article/MED/42133079 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fed06a0410da (Metraipolis archive dc_fed06a0410da, sha256 8eeb7ed716d7433daa10f4a2f352efaf87f5c61388f1739f7991ec9ad9de9f6d)
BibTeX
@misc{dcfed06a0410da,
  title = {Variability in anthracycline dose conversions and cardiotoxicity monitoring: insights from hospital pharmacists on institutional protocols in oncology practice — Europe PMC PMID:42133079},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42133079},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fed06a0410da; sha256 8eeb7ed716d7433daa10f4a2f352efaf87f5c61388f1739f7991ec9ad9de9f6d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42133079. Agents can read the archived copy with the MCP tool read_document.